Predictive Biomarkers for Peripheral Neuropathy in Adults
Several cardiac and kidney biomarkers may be used to identify older adults with peripheral neuropathy.
Diabetes
Diabetes Negatively Affects Pain Severity in Osteoarthritis
Patients with osteoarthritis and diabetes experience greater knee pain and worse physical and mental status compared with patients without diabetes.
Popliteal Sciatic Nerve Block May Increase Time to First Opioid Request in Diabetic Peripheral Neuropathy
Patients with type 2 diabetes and diabetic peripheral neuropathy may have an increased time to first opioid request and reduced time to onset of sensory blockade after an ultrasound-guided popliteal sciatic nerve block compared with patients without neuropathy.
Sustained-Release Sodium Nitrite for Diabetic Neuropathic Pain Not Associated With Headaches
A sustained-release formulation of sodium nitrite may not be associated with headaches and dizziness reported by patients treated with the immediate-release formulation of sodium nitrite for diabetic peripheral neuropathy.
Upcoming Study to Test Efficacy of Acupuncture in Treating Diabetic Peripheral Neuropathy
Investigators hypothesize that needle and laser acupuncture may improve clinical and subjective symptoms in patients with diabetic peripheral neuropathy.
Distinct Mechanisms Underlie Nerve Damage in Peripheral Neuropathy in Type 1 vs Type 2 Diabetes
The type of sciatic nerve lesions observed in patients with diabetic peripheral neuropathy was found to differ in type 1 and type 2 diabetes.
Diabetes, Insulin Therapies, and Migraine Risk
The presence of diabetes — both types 1 and 2 — may be associated with a reduced risk for migraine
Vitamin E May Not Improve Diabetic Peripheral Neuropathy-Associated Symptoms
Oral vitamin E supplementation consisting of 400 mg/day mixed tocotrienols for 1 year may not result in improved neuropathic pain symptoms in patients with diabetic peripheral neuropathy.
Chronic Migraine Linked to Insulin Resistance in Women
A recent study assessed the relationship of fasting neuropeptide Y with insulin resistance, β-cell function, and glucagon-like peptide-1 secretion in patients with migraine.
Type 1, Type 2 Diabetes Associated With Lower Risk for Migraine
Results from a study investigating diabetes and migraine in the Norwegian population show that type 1 and type 2 diabetes were significantly associated with a decreased risk for migraine.
-
Loading...
-
Loading...
Next post in Migraine & Headache
